Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0002084869-25-000001
Filing Date
2025-09-25
Accepted
2025-09-25 15:23:21
Documents
1
Period of Report
2025-09-16

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT primary_doc.html 3  
1 PRIMARY DOCUMENT primary_doc.xml 3 4990
  Complete submission text file 0002084869-25-000001.txt   6487
Mailing Address 120 PRESIDENTIAL WAY, SUITE 330 WOBURN MA 01801
Business Address 120 PRESIDENTIAL WAY, SUITE 330 WOBURN MA 01801 781-245-1325
Biofrontera Inc. (Issuer) CIK: 0001858685 (see all company filings)

EIN.: 473765675 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address HEMMELRATHER WEG 201 LEVERKUSEN Germany D-51377
Business Address
de la Huerta Martinez Maria del Pilar (Reporting) CIK: 0002084869 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-40943 | Film No.: 251343203